These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endocytic Recycling of MHC Class I Molecules in Non-professional Antigen Presenting and Dendritic Cells. Montealegre S; van Endert PM Front Immunol; 2018; 9():3098. PubMed ID: 30666258 [TBL] [Abstract][Full Text] [Related]
4. The role of MHC class I recycling and Arf6 in cross-presentation by murine dendritic cells. Montealegre S; Abramova A; Manceau V; de Kanter AF; van Endert P Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31740564 [TBL] [Abstract][Full Text] [Related]
5. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells. Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045 [TBL] [Abstract][Full Text] [Related]
6. Hematopoietic cells are required to initiate a Chlamydia trachomatis-specific CD8+ T cell response. Steele LN; Balsara ZR; Starnbach MN J Immunol; 2004 Nov; 173(10):6327-37. PubMed ID: 15528372 [TBL] [Abstract][Full Text] [Related]
7. Amphisomal route of MHC class I cross-presentation in bacteria-infected dendritic cells. Fiegl D; Kägebein D; Liebler-Tenorio EM; Weisser T; Sens M; Gutjahr M; Knittler MR J Immunol; 2013 Mar; 190(6):2791-806. PubMed ID: 23418629 [TBL] [Abstract][Full Text] [Related]
8. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells. Segura E; Villadangos JA Traffic; 2011 Dec; 12(12):1677-85. PubMed ID: 21777358 [TBL] [Abstract][Full Text] [Related]
9. Differential use of autophagy by primary dendritic cells specialized in cross-presentation. Mintern JD; Macri C; Chin WJ; Panozza SE; Segura E; Patterson NL; Zeller P; Bourges D; Bedoui S; McMillan PJ; Idris A; Nowell CJ; Brown A; Radford KJ; Johnston AP; Villadangos JA Autophagy; 2015; 11(6):906-17. PubMed ID: 25950899 [TBL] [Abstract][Full Text] [Related]
10. Functional characterization of class Ia- and non-class Ia-restricted Chlamydia-reactive CD8+ T cell responses in humans. Gervassi AL; Probst P; Stamm WE; Marrazzo J; Grabstein KH; Alderson MR J Immunol; 2003 Oct; 171(8):4278-86. PubMed ID: 14530352 [TBL] [Abstract][Full Text] [Related]
11. Impact of the TAP-like transporter in antigen presentation and phagosome maturation. Lawand M; Evnouchidou I; Baranek T; Montealegre S; Tao S; Drexler I; Saveanu L; Si-Tahar M; van Endert P Mol Immunol; 2019 Sep; 113():75-86. PubMed ID: 29941219 [TBL] [Abstract][Full Text] [Related]
12. Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway. Win SJ; Ward VK; Dunbar PR; Young SL; Baird MA Immunol Cell Biol; 2011 Aug; 89(6):681-8. PubMed ID: 21221122 [TBL] [Abstract][Full Text] [Related]
13. Rab22a: A novel regulator of immune functions. Mayorga LS; Cebrian I Mol Immunol; 2019 Sep; 113():87-92. PubMed ID: 29631761 [TBL] [Abstract][Full Text] [Related]
14. Discordance in the Epithelial Cell-Dendritic Cell Major Histocompatibility Complex Class II Immunoproteome: Implications for Chlamydia Vaccine Development. Karunakaran KP; Yu H; Jiang X; Chan QWT; Foster LJ; Johnson RM; Brunham RC J Infect Dis; 2020 Feb; 221(5):841-850. PubMed ID: 31599954 [TBL] [Abstract][Full Text] [Related]
15. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design. Herrera OB; Brett S; Lechler RI Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698 [TBL] [Abstract][Full Text] [Related]
16. Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I. Horrevorts SK; Duinkerken S; Bloem K; Secades P; Kalay H; Musters RJ; van Vliet SJ; García-Vallejo JJ; van Kooyk Y Front Immunol; 2018; 9():1231. PubMed ID: 29963041 [TBL] [Abstract][Full Text] [Related]
17. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Rodriguez A; Regnault A; Kleijmeer M; Ricciardi-Castagnoli P; Amigorena S Nat Cell Biol; 1999 Oct; 1(6):362-8. PubMed ID: 10559964 [TBL] [Abstract][Full Text] [Related]
18. CD9 Regulates Major Histocompatibility Complex Class II Trafficking in Monocyte-Derived Dendritic Cells. Rocha-Perugini V; Martínez Del Hoyo G; González-Granado JM; Ramírez-Huesca M; Zorita V; Rubinstein E; Boucheix C; Sánchez-Madrid F Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28533221 [TBL] [Abstract][Full Text] [Related]
19. IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing. Spadaro F; Lapenta C; Donati S; Abalsamo L; Barnaba V; Belardelli F; Santini SM; Ferrantini M Blood; 2012 Feb; 119(6):1407-17. PubMed ID: 22184405 [TBL] [Abstract][Full Text] [Related]
20. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]